Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneious Melanoma
Study Type: Treatment
Phase: III
NCTID: NCT03860883
Principal Investigator:
Luke Selby
Randomized Phase II/III Study Of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab In Patients With Unresectable State III Or Stage IV Melanoma
A Phase II and Pilot Trial of PD-1 Blockade with MK-3475 Pembrolizumab in Patients with Resectable of Unresectable Desmoplastic Melanoma DM
A Phase I/II Study of Pembrolizumab MK-3475 in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma KEYNOTE-051
Study Type: Treatment
Phase: I/II
NCTID: NCT02332668
Principal Investigator:
Jaszianne Tolbert
A Randomized Phase II Study of ATR Inhibition in Advanced PD-L1-refractory Merkel Cell Carcinoma: The MATRiX Trial
Study Type: Treatment
Phase: II
NCTID: NCT05947500
Principal Investigator:
Nina Mathew